- Home
- RCON
RCON
Recon Technology Ltd.
as 03-28-2025 4:00pm EST
| Founded: | 2007 | Country: | China |
| Employees: | N/A | City: | BEIJING |
| Market Cap: | N/A | IPO Year: | 2009 |
| Target Price: | N/A | AVG Volume (30 days): | 9.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.26 - $3.70 | Next Earning Date: | 01-01-0001 |
| Revenue: | $9,475,055 | Revenue Growth: | 2.59% |
| Revenue Growth (this year): | -83.41% | Revenue Growth (next year): | 15.18% |
Latest Recon Technology Ltd. News
RCON Breaking Stock News: Dive into RCON Ticker-Specific Updates for Smart Investing
PR Newswire
5 months ago
Recon Technology, Ltd Reports Financial Year Results for Fiscal Year 2024
PR Newswire
9 months ago
Recon Technology, Ltd Reports Financial Results for the First Six Months of Fiscal Year 2024
Yahoo Finance Video
10 months ago
FDA panel votes to recommend Eli Lilly's Alzheimer's drug
GlobeNewswire
10 months ago
Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis
Reuters
10 months ago
California seeks company profits in Big Oil climate lawsuit
USA TODAY
10 months ago
S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead
Business Wire
10 months ago
Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
GlobeNewswire
10 months ago
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
Compare RCON vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RCON Recon Technology Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.